Dr. Cliff Shunsheng Ham, the inventor of AllerPops, cuts a ribbon at SALA Events Center Thursday during an event celebrating the expansion of the AllerPops line to include new products and new flavors. He is surrounded by family members, friends, associates and community members. Photo by Maire O’Neill/losalamosreporter.com
Dr, Cliff Shunsheng, center, with Ryn Hermann, executive director of the Los Alamos Chamber of Commerce and Allan Saenz, owner of SALA Los Alamos Events Center. Photo by Maire O’Neill/losalamosreporter.com
BY MAIRE O’NEILL
maire@losalamosreporter.com
Cliff Shunsheng Han on Thursday kicked off the next chapter of AllerPops with a celebration at SALA Los Alamos Event Center.
Sporting a bright yellow jacket, Han addressed friends, investors, associates and family members with a slideshow and speech, drawing applause over and over from the audience.
He said almost 70 years ago on July 16, 1945, Los Alamos residents got up early, wrapped themselves in blankets and sat outside to experience the unknown.
“They were not prepared for what they were about to see just above the Los Alamos mountains. As rumor had it, twilight came early that day – and from the south, not the east,” Han said. “Most did not know it then but they were witnessing the arrival but they were witnessing the arrival of a new beginning, the atomic age. That leads us to today. We, the champions of AllerPops, have gathered here to witness another first light coming to the world: The beginning of the end of the allergy era.”
Han said that of course he would never actually compare the atomic bomb with his company but that they do have some similarities. He said he believes and knows that AllerPops is the end of the allergy epidemic that plagues millions of people.
“Allergies have been getting worse and worse in the last 50 years, with longer seasons and higher pollen counts. The number of US allergy sufferers even doubled in the last 10 years, from 50 million to 100 million,” Han said. “But let me tell you the good news – we have the solution! For the first time in history, we have built a product that can cure and prevent your allergies.”
He said AllerPops goes after the root cause of allergies, which is the lack of good bacteria in the mouth, not just the symptoms, and can relieve allergies for months to years.
“We have come a long way in proving AllerPops works. My life experiences and background have prepared me for the journey to solving allergy suffering. My unique perspective, medical education and involvement in the human genome project allowed me to study the oral microbiome and allergies. Personal suffering in my family motivated me to face the unknown without fear,” Han said
After three years of research he developed an antidote that worked well for him and went on to test multiple formulas to create a customer-friendly product. AllerPops was launched in 2018 and received supportive feedback. Since then, he said, significant improvements have been made.
“For those aware of clinical trial regulations, I’m proud to share that AllerPops has completed our Phase 2 clinical trial, which is a decisive process to see if a drug, or in our case a supplement, works. The trial process is heavily regulated by government agencies such as the FDA and takes a tremendous amount of effort but it was worth it,” Han said. “The independent clinical trial confirmed AllerPops’ effectiveness in providing sustained allergy relief, and the trial data showed that AllerPops promotes good oral bacteria, addressing the root cause of allergies. With evidence from our pilot study, customer feedback and the clinical trial, I am confident that AllerPops is the ultimate solution for allergies.”
He said more than 12,000 people have used the products and they are using words like are using words like “miracle” and “god-sent” to describe their experience.
“According to our customer satisfaction survey, AllerPops efficacy is high. It is 95% effective for nasal congestion, 89% for runny nose, 80% for asthma and 50% for arthritis. AllerPops can relieve those non-allergy conditions because it treats the root cause, the hypersensitive immune system. AllerPops can reduce inflammation in other places by calming down the immune system,” Han said.
He announced the expansion of the original AllerPops into a new lozenge version and the addition of many new flavors. He said all the products are made with all natural, FDA-approved food ingredients, designed to maximize the growth of the beneficial bacteria in the mouth.
“Based on our customers’ feedback, the first batch of the lozenge has been manufactured and will be available in a month and we will also be launching the new fruit flavors,” Han said. “On average people need about 6 pops to attain allergy relief that will last for weeks, months to years. Our prebiotic toothpaste can help you to maintain lasting relief.”
Han announced three new products, AllerPaste, Aller Fresh and Allerpups.
“Allerpaste, our prebiotic toothpaste, has traditional cleaning agents that are gentle to beneficial bacteria and help them recover with added prebiotics. This was just launched recently and is now shipping to customers nationwide. AllerFresh are mouthwash tablets that can quickly clean the mouth and leave a peppermint fresh scent behind. AllerPups are allergy supplements for our furry friends. In case you wonder, dogs can have allergies too. They sneeze and cough just like we do, and itchy skin is the most common symptom for allergic dogs. Customers who have tried AllerPups report similar benefits to our core product,” Han said. “The impact of introducing new products is big. Our average purchase value has increased by 50%.”
He said AllerPops potential is huge, with 100 million people in the United States who suffer from allergies spending some $18 billion on allergy and asthma-related issues. He believes his product is a disruptive solution that will replace current symptom-treating remedies.
“We will brand AllerPops as the future leader in allergy relief and related areas. We expect the company will grow fast within the next five years. We hope our expansion will benefit and profit many people in our community,” Han said..
He noted that AllerPops is fully mature and read for market expansion and that the national campaign to liberate millions of allergy sufferers is starting.
“We have an acting funding round open for those who would like to learn more about participating. You can visit allerpops.com for more information. I’d love to have you on board as we change the future of allergies,” Han said.
Los Alamos County Councilor Suzie Havemann, far left, chats with Shannon CDebaca, center, and Lavonne Pierson at the AllerPops reception Thursday at SALA. Photo by Maire O’Neill/losalamosreporter.com
Travis Brodeen, left, founder of MVP Institute and co-founder of the online startup accelerator Newchip chats with Sen. Leo Jaramillo at SALA Thursday during the AllerPops reception. Photo by Maire O’Neill/losalamosreporter.com
Dr. Cliff Shunsheng Han signs and distributes copies of his book, ‘Nothing to Sneeze At’ for guests at the AllerPops reception Thursday at SALA. Photo by Maire O’Neill/losalamosreporter.com
Some of the guests at Thursday’s AllerPop reception at SALA. Photo by Maire O’Neill/losalamosreporter.com
Dr. Cliff Shusheng Han speaks to his guests in one of the theaters at SALA Thursday. Photo by Maire O’Neill/losalamos reporter.com
Dr. Cliff Shusheng Han smiles broadly as he prepares to take the giant scissors to cut the celebratory yellow ribbon recognizing the success and future plans of AllerPops. Photo by Maire O’Neill/losalamosreporter.com